D Facchin1, M S Baccillieri2, G Gasparini3, F Zoppo4, G Allocca5, M Brieda6, R Verlato2, A Proclemer7. 1. Azienda Sanitaria Universitaria Integrata di Udine, Italy. Electronic address: facchin.domenico@aoud.sanita.fvg.it. 2. Ospedale P. Cosma, Camposampiero, Italy. 3. Ospedale dell'Angelo, Mestre, Italy. 4. Azienda Ospedaliera di Mirano, Mirano, Italy. 5. Ospedale di Conegliano, Conegliano, Italy. 6. Ospedale Santa Maria degli Angeli, Pordenone, Italy. 7. Azienda Sanitaria Universitaria Integrata di Udine, Italy.
Abstract
BACKGROUND: Device follow-up is mandatory in the care of patients with a pacemaker. However, in most cases, device checks appear to be mere technical, time-consuming procedures. The aim of this research is to evaluate whether remote follow-up can replace in-clinic device checks by assessing clinical outcomes for pacemaker patients followed only via remote follow-up. METHODS AND RESULTS: Consecutive pacemaker patients followed with remote monitoring were prospectively included by 6 Italian cardiology centers in an observational investigation. The workflow for remote monitoring included an initial assessment by nursing staff and, when necessary, by a responsible physician for medical decisions. No in-person visits were scheduled after the start of remote monitoring. One-thousand and two-hundred and fifty one patients (30% female, 75±11years old) were followed for a median observation period of 15months. Out of 4965 remote transmissions, 1882 (38%) had at least one clinically relevant event to be investigated further, but, only after 137 transmissions (2.8%), the patients were contacted for an in-clinic visit or hospitalization. Sixty-nine patients died and 124 were hospitalized for various reasons. Atrial fibrillation episodes were the most common clinical events discovered by remote transmissions, occurring in 1339 (26%) transmissions and 471 (38%) patients. CONCLUSIONS: Our experience shows that remote monitoring in a pacemaker population can safely replace in-clinic follow-up, avoiding unnecessary in-hospital device follow-up.
BACKGROUND: Device follow-up is mandatory in the care of patients with a pacemaker. However, in most cases, device checks appear to be mere technical, time-consuming procedures. The aim of this research is to evaluate whether remote follow-up can replace in-clinic device checks by assessing clinical outcomes for pacemaker patients followed only via remote follow-up. METHODS AND RESULTS: Consecutive pacemaker patients followed with remote monitoring were prospectively included by 6 Italian cardiology centers in an observational investigation. The workflow for remote monitoring included an initial assessment by nursing staff and, when necessary, by a responsible physician for medical decisions. No in-person visits were scheduled after the start of remote monitoring. One-thousand and two-hundred and fifty one patients (30% female, 75±11years old) were followed for a median observation period of 15months. Out of 4965 remote transmissions, 1882 (38%) had at least one clinically relevant event to be investigated further, but, only after 137 transmissions (2.8%), the patients were contacted for an in-clinic visit or hospitalization. Sixty-nine patients died and 124 were hospitalized for various reasons. Atrial fibrillation episodes were the most common clinical events discovered by remote transmissions, occurring in 1339 (26%) transmissions and 471 (38%) patients. CONCLUSIONS: Our experience shows that remote monitoring in a pacemaker population can safely replace in-clinic follow-up, avoiding unnecessary in-hospital device follow-up.
Authors: Francisco Javier García-Fernández; Joaquín Osca Asensi; Rafael Romero; Ignacio Fernández Lozano; José María Larrazabal; José Martínez Ferrer; Raquel Ortiz; Marta Pombo; Francisco José Tornés; Mehrard Moradi Kolbolandi Journal: Eur Heart J Date: 2019-06-14 Impact factor: 29.983
Authors: Antonio Lopez-Villegas; Daniel Catalan-Matamoros; Salvador Peiro; Knut Tore Lappegard; Remedios Lopez-Liria Journal: PLoS One Date: 2020-01-29 Impact factor: 3.240